Evidence map›Paper›PMID 27379035›Full record

ArticleFrontiers in microbiology2016

Antifungal and Zearalenone Inhibitory Activity of Pediococcus pentosaceus Isolated from Dairy Products on Fusarium graminearum.

Muthulakshmi Sellamani, Naveen K Kalagatur, Chandranayaka Siddaiah, Venkataramana Mudili, Kadirvelu Krishna, Gopalan Natarajan, Venkata L Rao Putcha

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. ExploringMarine drugs · 2024
    Article
  3. Article
  4. Article
  5. Draft genome sequencing ofMicrobiology resource announcements · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Metabolites fromACS omega · 2023
    Article
  10. Article
  11. Article
  12. Frontiers in microbiology · 2023
    Review
  13. Flavonoids ModulateJournal of fungi (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Biosynthesis of Selenium Nanoparticles (viaMolecules (Basel, Switzerland) · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Muthulakshmi SellamaniToxicology and Immunology Division, DRDO-BU-Centre for Life sciences, Bharathiar University Campus, Coimbatore India.
Naveen K KalagaturFood Microbiology Division, Defence Food Research Laboratory Mysore, India.
Chandranayaka SiddaiahDepartment of Biotechnology, University of Mysore Mysore, India.
Venkataramana MudiliToxicology and Immunology Division, DRDO-BU-Centre for Life sciences, Bharathiar University Campus, Coimbatore India.
Kadirvelu KrishnaToxicology and Immunology Division, DRDO-BU-Centre for Life sciences, Bharathiar University Campus, CoimbatoreIndia; Defence Bioengineering and Electromedical LaboratoryBangalore, India.
Gopalan NatarajanFood Biotechnology Division, Defence Food Research Laboratory Mysore, India.
Venkata L Rao PutchaToxicology and Immunology Division, DRDO-BU-Centre for Life sciences, Bharathiar University Campus, Coimbatore India.
Bharathiar University · INDefence Food Research Laboratory · INDefence Bioengineering and Electromedical Laboratory · INUniversity of Mysore · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was aimed to evaluate the bio-control efficacy of Pediococcus pentosaceus isolated from traditional fermented dairy products originated from India, against the growth and zearalenone (ZEA) production of Fusarium graminearum. The cell-free supernatants of P. pentosaceus (PPCS) were prepared and chemical profiling was carried out by GC-MS and MALDI-TOF analysis. Chemical profiling of PPCS evidenced that, the presence of phenolic antioxidants, which are responsible for the antifungal activity. Another hand, MALDI-TOF analysis also indicated the presence of antimicrobial peptides. To know the antioxidant potential of PPCS, DPPH free radical scavenging assay was carried out and IC50 value was determined as 32 ± 1.89 μL/mL. The antifungal activity of P. pentosaceus was determined by dual culture overlay technique and zone of inhibition was recorded as 47 ± 2.81%, and antifungal activity of PPCS on F. graminearum was determined by micro-well dilution and scanning electron microscopic techniques. The minimum inhibitory concentration (MIC) of PPCS was determined as 66 ± 2.18 μL/mL in the present study. Also a clear variation in the micromorphology of mycelia treated with MIC value of PPCS compared to untreated control was documented. Further, the mechanism of growth inhibition was revealed by ergosterol analysis and determination of reactive oxygen species (ROS) in PPCS treated samples. The effects of PPCS on mycelial biomass and ZEA production were observed in a dose-dependent manner. The mechanism behind the suppression of ZEA production was studied by reverse transcriptase qPCR analysis of ZEA metabolic pathway genes (PKS4 and PKS13), and results showed that there is a dose dependent down-regulation of target gene expression in PPCS treated samples. The results of the present study were collectively proved that, the antifungal and ZEA inhibitory activity of PPCS against F. graminearum and it may find a potential application in agriculture and food industry as a natural bio-controlling agent.

Indexed as

dual culture overlay techniqueergosterolF. graminearumminimum inhibitory concentrationP. pentosaceusreactive oxygen speciesreverse transcriptase qPCR analysisZearalenone

Identifiers

PMID27379035
PMCPMC4904835
OpenAlexW2424385993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.